Krajina: Austrália
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
Influenza virus haemagglutinin, Quantity: 30 microgram/mL
Seqirus Pty Ltd
Influenza virus haemagglutinin
Injection, suspension
Excipient Ingredients: monobasic potassium phosphate; water for injections; thiomersal; calcium chloride dihydrate; dibasic sodium phosphate; potassium chloride; sodium chloride; monobasic sodium phosphate
Intramuscular
For active immunization against influenza disease caused by influenza subtype viruses and type B viruses contained in the vaccine.
Visual Identification: Clear to slightly opaque liquid containing some sediment which readily resuspends upon shaking; Container Type: Bulk Container; Container Life Time: 10 Weeks; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2017-04-12